Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.
2.

Effect of carbazochrome salicylate on transplacental transmission of fetal erythrocytes.

Messer RH, Pearse WH, Keenan H.

Obstet Gynecol. 1966 Jan;27(1):83-8. No abstract available.

PMID:
5900650
3.

[Attempted prevention of feto-maternal immunization by blocking the transplacental passage of fetal erythrocytes].

Mahon R, Dubecq JP, Bastide, Mirebeau P.

Bull Fed Soc Gynecol Obstet Lang Fr. 1968;20(5):Suppl:428-9. French. No abstract available.

PMID:
5759266
4.

Transplacental passage of fetal erythrocytes during pregnancy.

Clayton EM Jr, Feldhaus W, Phythyon JM, Whitacre FE.

Obstet Gynecol. 1966 Aug;28(2):194-7. No abstract available.

PMID:
4957669
5.

[Have the citro-flavonoids and the derivatives of adrenochrome still a place in the prevention of feto-maternal immunization and perinatal hemolytic disease?].

Mahon R, Dubecq JP, Leng JJ, Mirebeau P.

Rev Fr Gynecol Obstet. 1970 Jan-Feb;65(1):39-43. French. No abstract available.

PMID:
4985711
6.

[CONTRIBUTION TO THE STUDY OF TRANSPLACENTAL PASSAGE OF THE FETAL ERYTHROCYTES].

DUBECQ JP, SOUMIREU-MOURAT R.

Bull Fed Soc Gynecol Obstet Lang Fr. 1964 Sep-Oct;16:418-9. French. No abstract available.

PMID:
14273546
7.

The use of the bioflavonoid compounds in the prevention or reduction in severity of erythroblastosis fetalis.

JACOBS WM.

Surg Gynecol Obstet. 1956 Aug;103(2):233-6. No abstract available.

PMID:
13352150
8.

[TRANSPLACENTAL BLOOD EXCHANGES].

DAVID G, LEROUX JP.

Nouv Rev Fr Hematol. 1964 Jan-Feb;4:101-9. French. No abstract available.

PMID:
14122836
9.

PREVENTION OF ERYTHROBLASTOSIS FETALIS. A PRELIMINARY STUDY USING CARBAZOCHROME SALICYLATE.

MASSEY GD.

Obstet Gynecol. 1964 May;23:712-5. No abstract available.

PMID:
14196401
10.

[Use of citroflavonoids in the prevention of complications due to fetomaternal blood incompatibility].

Garès R.

Bull Fed Soc Gynecol Obstet Lang Fr. 1966 Jun-Aug;18(3):288-90. French. No abstract available.

PMID:
5962895
11.

Therapeutic evaluation of citrus bio-flavonoids in the prevention of erythroblastosis.

ROGERS GC, FLEMING JM.

West J Surg Obstet Gynecol. 1955 Jun;63(6):386-8. No abstract available.

PMID:
14386805
12.

Transplacental passage of maternal erythrocytes. Studies in early pregnancy.

Donovan JC, Lund CJ.

Am J Obstet Gynecol. 1966 Jul 15;95(6):834-7. No abstract available.

PMID:
5949529
13.

[THE PASSAGE OF FETAL AND MATERNAL ERYTHROCYTES ACROSS THE PLACENTA].

HELDERWEIRT G.

Ann Soc Belg Med Trop (1920). 1963 Aug 31;43:575-94. French. No abstract available.

PMID:
14109563
14.

[On the problem of the passage of fetal erythrocytes into the maternal circulation].

Kreig H, Göltner E, Schmidt H.

Med Welt. 1966 May 14;20:1123-7. German. No abstract available.

PMID:
5984493
15.
16.
17.

[CONSIDERATIONS ON THE TRANSPLACENTAL PASSAGE OF FETAL ERYTHROCYTES].

CURIEL P, CUTRERA A.

Riv Ostet Ginecol. 1964 May;19:264-71. Italian. No abstract available.

PMID:
14166811
18.

[Transplacental passage of erythrocytes].

Ravina JH.

Maternite. 1965 Sep;14(9):319-26. French. No abstract available.

PMID:
5850030
19.

[The effect of galascorbin on the acid-alkaline balance of the blood in pregnant women].

Kaminskaia VT.

Vopr Okhr Materin Det. 1968 Jan;13(1):91-2. Russian. No abstract available.

PMID:
5719534
20.

[On the passage of fetal erythrocytes into the maternal circulation and prevention of perinatal hemolytic disease].

Botella Llusiá J.

An R Acad Nac Med (Madr). 1966;83(2):159-67. Spanish. No abstract available.

PMID:
5952983

Supplemental Content

Support Center